Skip to main content
Fig. 2 | BMC Cancer

Fig. 2

From: Feasibility of dynamic risk assessment for patients with repeated trans-arterial chemoembolization for hepatocellular carcinoma

Fig. 2

Kaplan-Meier survival curves of A-B vs. C-D class mHAP-II (a), mHAP (b), and HAP (c) risk scores at the second TACE among patients who showed A-B class risk scores at the first TACE. Patients with A-B class risk scores showed significantly better survival than those with C-D class risk scores at the second TACE. mHAP, modified hepatoma arterial-embolization prognostic; TACE, trans-arterial chemoembolization

Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us